This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The evolution of clinical trials for infant acute lymphoblastic leukemia
Blood Cancer Journal Open Access 11 April 2014
-
Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling
Cell Death & Disease Open Access 09 August 2012
-
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
British Journal of Cancer Open Access 09 August 2005
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ito C, Kumagai M, Manabe A, Coustan-Smith E, Raimondi SC, Behm FG et al. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood 1999; 93: 315–320.
Wuchter C, Karawajew L, Ruppert V, Buchner T, Schoch C, Haferlach T et al. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics. Leukemia 1999; 13: 1943–1953.
Baryshnikov AYu, Polosukhina ER, Tupitsin NN, Gavrikova NV, Andreeva LYu, Zabotina TN et al. CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients. Adv Exp Med Biol 1999; 457: 251–258.
Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R et al. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia. Br J Haematol 2000; 110: 154–160.
Findley HW, Zhou M . The clinical significance of Fas expression in leukemia: questions and controversies. Leukemia 1999; 13: 147–149.
Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 2000; 6: 1796–1803.
Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB . Characterization of XIAP-deficient mice. Mol Cell Biol 2001; 21: 3604–3608.
Clem RJ, Sheu TT, Richter BW, He WW, Thornberry NA, Duckett CS et al. c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment. J Biol Chem 2001; 276: 7602–7608.
Acknowledgements
We thank the participating institutions of the Japan Infant Leukemia Study Group for providing patients' samples and their data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suminoe, A., Matsuzaki, A., Hattori, H. et al. mRNA expression of apoptosis-associated genes in infant acute lymphoblastic leukemia: low Fas expression is an independent predictor for poor prognosis. Leukemia 18, 365–368 (2004). https://doi.org/10.1038/sj.leu.2403228
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403228
This article is cited by
-
The evolution of clinical trials for infant acute lymphoblastic leukemia
Blood Cancer Journal (2014)
-
Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling
Cell Death & Disease (2012)
-
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
Nature Communications (2012)
-
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
British Journal of Cancer (2005)